Figures
Tables
Supplementary subjects, methods and results
Summarised description of the cohorts presented in the study; Genotyping and quality assessment; Table E1: Definitions of the Allergenic study, potential confounders and environmental exposures; Table E2: Association of IL-13 SNPs with total serum IgE levels at all ages in (A) Pooled data (Allergenic), and in (B) PIAMA, (C) PREVASC and (D) KOALA separately; Table E3: Interaction of CD14 genotypes and combined pet exposure (cat and/or dog) with respect to total serum IgE levels at ages 4 and 8 years; Table E4: Interaction of CD14 genotypes with combined pet exposure (cat and/or dog) in the development of sensitisation to any allergen at age 8 years; Table E5: Interaction of CD14 genotypes with dog exposure with respect to total serum IgE levels at age 4 and 8 years; Table E6: Interaction of CD14 genotypes with dog exposure in the development of sensitisation to any allergen at age 8 years; Table E7: Interaction of CD14 genotypes and cat exposure with respect to total serum IgE levels at ages 4 and 8 years; Table E8: Interaction of CD14 genotypes with cat exposure in the development of sensitisation to any allergen at age 8 years; Table E9: Interaction of CD14 genotypes and environmental tobacco smoke exposure (ETS) with respect to total serum IgE levels at age 4 years.
Files in this Data Supplement:
- Supplementary subjects, methods and results - Summarised description of the cohorts presented in the study; Genotyping and quality assessment; Table E1: Definitions of the Allergenic study, potential confounders and environmental exposures; Table E2: Association of IL-13 SNPs with total serum IgE levels at all ages in (A) Pooled data (Allergenic), and in (B) PIAMA, (C) PREVASC and (D) KOALA separately; Table E3: Interaction of CD14 genotypes and combined pet exposure (cat and/or dog) with respect to total serum IgE levels at ages 4 and 8 years; Table E4: Interaction of CD14 genotypes with combined pet exposure (cat and/or dog) in the development of sensitisation to any allergen at age 8 years; Table E5: Interaction of CD14 genotypes with dog exposure with respect to total serum IgE levels at age 4 and 8 years; Table E6: Interaction of CD14 genotypes with dog exposure in the development of sensitisation to any allergen at age 8 years; Table E7: Interaction of CD14 genotypes and cat exposure with respect to total serum IgE levels at ages 4 and 8 years; Table E8: Interaction of CD14 genotypes with cat exposure in the development of sensitisation to any allergen at age 8 years; Table E9: Interaction of CD14 genotypes and environmental tobacco smoke exposure (ETS) with respect to total serum IgE levels at age 4 years.